Figure 1.
Effect of Win-55212-2 (0.3, 1, and 5 mg/kg) treatment on elevated plus-maze performance: total distance covered by rats (A), the percentage of entries in open arms (B), time spent in open arms (C) and number of closed arms entry (D) during the 10 min test session in EPM. Data were analyzed by one-way ANOVA followed by Tukey–Kramer test (n= 10 per group). * P<0.05, and ** P<0.01 compared to control (saline).